GlassScriptPhysician profile
Heba S Ferguson
NPI 1881603421
$9,758.20
in general payments reported to CMS, 2019-2025
44 companies · $1,753 in 2025
The $1,753 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,115 · 2020: $1,050 · 2021: $1,298 · 2022: $1,366 · 2023: $1,569 · 2024: $1,607 · 2025: $1,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,825 · Education: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,825.22 |
| Education | $103.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,626.96 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $1,177.41 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $966.22 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $582.93 | 2020-2025 | |
| Astellas Pharma US INC | $552.78 | 2019-2025 | Veozah, Myrbetriq |
| Amarin Pharma, INC. | $474.08 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $406.43 | 2019-2025 | Xarelto, Spravato |
| Amgen INC. | $397.16 | 2019-2025 | Evenity, Prolia, Repatha |
| Glaxosmithkline, LLC. | $392.20 | 2019-2025 | Trelegy Ellipta, Bexsero, Penmenvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $375.66 | 2019-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $268.97 | 2021-2025 | Xifaxan, Trulance |
| Sanofi-Aventis U.S. LLC | $260.10 | 2019-2023 | |
| Abbott Laboratories | $255.22 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $252.87 | 2019-2023 | Belsomra, Steglatro |
| Bayer Healthcare Pharmaceuticals INC. | $240.81 | 2022-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heba Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.